Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
121.41
+2.17 (+1.82%)
Official Closing Price
Updated: 7:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,102,343
Open
121.50
Bid (Size)
120.97 (100)
Ask (Size)
121.41 (1,600)
Prev. Close
119.24
Today's Range
121.03 - 123.33
52wk Range
73.31 - 123.33
Shares Outstanding
2,531,374,696
Dividend Yield
2.80%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
↗
Today 5:45 EST
And now may be the right time to look for something other than artificial intelligence (AI)-driven growth.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
February 13, 2026
Moderna Inc. (NASDAQ: MRNA) shares jumped 8% in early trading on February 13, 2026, after the biotechnology pioneer reported fourth-quarter 2025 financial results that exceeded Wall Street’s...
Via
MarketMinute
Topics
Earnings
Performance
YTD
+14.1%
+14.1%
1 Month
+9.4%
+9.4%
3 Month
+30.7%
+30.7%
6 Month
+44.2%
+44.2%
1 Year
+43.8%
+43.8%
More News
Read More
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
↗
February 13, 2026
Via
The Motley Fool
Dow Jones 267-Point Slide: Blue-Chip Leaders and the AI Reality Check
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
3 Mega-Cap Stocks for Long-Term Investors
February 12, 2026
Via
StockStory
Topics
Supply Chain
The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
February 12, 2026
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
February 12, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
February 12, 2026
From
Merck & Co., Inc.
Via
Business Wire
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
February 11, 2026
From
Merck & Co., Inc.
Via
Business Wire
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
5 Revealing Analyst Questions From Merck’s Q4 Earnings Call
February 10, 2026
Via
StockStory
Topics
Earnings
Intellectual Property
Stock Market Today, Feb. 9: Oracle Climbs on AI Optimism Despite Software Sector Weakness
↗
February 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
3 Top Dow Jones Dividend Stocks to Buy for Passive Income in 2026
↗
February 08, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Stocks
AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology
February 06, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Fiscal Brinkmanship: Data Blackout and the DHS Cliff Loom Over Markets After Narrow Funding Deal
February 06, 2026
Via
MarketMinute
Topics
Economy
Government
Immigration
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
February 06, 2026
Via
Finterra
Topics
Economy
Government
Intellectual Property
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports
↗
February 05, 2026
Via
Stocktwits
Topics
Economy
Government
World Trade
USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border
February 05, 2026
Via
MarketMinute
Topics
Death
Economy
AI Panic Hits Software, PayPal Faceplants, Walmart Joins the $1T Club
↗
February 04, 2026
Via
Chartmill
Topics
Artificial Intelligence
How Merck Is Preparing For The Patent Cliff Of Its Blockbuster Cancer Drug Keytruda
↗
February 04, 2026
Via
Stocktwits
Topics
Earnings
Intellectual Property
MRK Q4 Deep Dive: Pipeline Expansion and New Product Launches Shape Guidance
February 04, 2026
Via
StockStory
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 121.41
When was Merck & Co last traded?
The last trade of Merck & Co was at 02/13/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 307.33B
How many shares of Merck & Co are outstanding?
Merck & Co has 307B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.